Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care.
Environmental responsibility has been on the agenda for Novo Nordisk since 1975 with the inception of a dedicated environmental department and adoption of a corporate policy. Since then, the company has proactively sought to provide transparent disclosure of practices and performance, achievements and challenges. It’s first environmental report in 1994 was a break-through, a ‘first’ in Denmark, preceding the adoption of mandatory green accounts for Danish companies. Conducting an Environmental Profit & Loss Account (EP&L) was a natural step to enhance the company’s reporting and efforts to create results in a Triple Bottom Line perspective.
“We have learned a lot from calculating the EP&L for Novo Nordisk. It has given the organisation valuable insights into the value of the externalities related to purchases in our supply chain and use at our production sites. We look forward to the continued deliberation on how the EP&L methodology can be used to inform decision-making”.
Novo Nordisk’s Environmental Profit and Loss Account (publication)